Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-2518-2025

Merge Healthcare, Inc. recalls Merge Hemo

Merge Healthcare, Inc.Hartland, WI, United StatesReported Sep 10, 2025 · 10 months ago
Legal News Analyst ·

Reason for recall

Merge Healthcare has been informed by Schiller AG (Baar, Switzerland) of an issue with the Schiller ARGUS PB-3000 Patient Data Module (PDM) where certain units trigger an error message on the Merge Hemo Client (Pressure Sensor Defective) during non-invasive blood pressure (NIBP) measurements, specifically when the initial inflation pressure is set in the high-pressure range (>240 mmHg). The ARGUS PB-3000 is a vital signs monitoring instrument intended to be integrated into the Merge Hemo System. No other components of the Merge Hemo System are affected.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Merge Hemo, Model RCSV2, Model/Catalog Number 99-01172-00, software versions 11.1 and 11.1.1 Product Description: The Merge Hemo, Model RCSV2 device is a hemodynamics recording computer system that monitors, measures, displays, records and stores various physiologic and blood flow parameters based on the output from one or more electrodes, transducers, or measuring devices. The system is used for documenting and monitoring patients undergoing diagnostic and interventional catheter-based procedures. The procedures can be performed in the clinical areas of invasive cardiology, interventional radiology, and cardiac electrophysiology
    Model Name
    84 affected lots
    7012.0000357012.0000367012.0000377012.0000387012.0000417012.0000427012.0000447012.000045
    +76 more7012.0000467012.0000477012.0000487012.0000507012.0000517012.0000527012.0000537012.0000577012.0000587012.0000597012.0000607012.0000617012.0000627012.0000637012.0000647012.0000657012.0000667012.0000677012.0000687012.0000697012.0000717012.0000727012.0000737012.0000747012.0000757012.0000767012.0000787012.0000797012.0000807012.0000817012.0000827012.0000837012.0000857012.0000877012.0000887012.0000897012.0000907012.0000917012.0000927012.0000937012.0000947012.0000977012.0000987012.0000997012.0001007012.0001017012.0001027012.0001037012.0001047012.0001057012.0001067012.0001077012.0001087012.0001097012.0001107012.0001117012.0001127012.0001137012.0001147012.0001157012.0001167012.0001177012.0001187012.0001197012.0001207012.0001237012.0001247012.0001257012.0001267012.0001377012.0001387012.0001407012.0001417012.0001427012.0001577012.000176

What the firm is doing

Merge Healthcare issued a Field Safety Corrective Action notice to its consignees on 08/12/2025 via email. The notice explained the issue with the device, potential risk to patients, and requested the following actions: Immediate actions to reduce risk to patients For customers using affected versions of Merge Hemo, the following action should be taken to mitigate the risk of non-invasive blood pressure (NIBP) becoming non-functional in the high-pressure range (>240 mmHg): " Ensure an alternative method for determining NIBP, such as a sphygmomanometer or other NIBP measuring device, is available during use of the Merge Hemo system. Actions being taken by Merge Merge Healthcare will contact you to arrange a no-charge inspection of your ARGUS PB-3000 device(s). If the device is affected by this issue, Merge Healthcare will provide a replacement ARGUS PB-3000 and send the affected device to Schiller AG. Please forward this notice to any individuals within your organization that may need to be aware of this notification. Customers should alert any other affiliated parties that may be affected by this Field Safety Corrective Action. Customers experiencing the reported issue should contact Merge Healthcare Support at 1-877-741-5369.

DistributionShow details

US Nationwide distribution including in the states of Arizona, Arkansas, California, Florida, Louisiana, Mississippi, North Carolina, North Dakota, Oklahoma, Pennsylvania, Georgia, Illinois, Kentucky, Tennessee, Texas, Washington, and Wisconsin.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls